C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/1998
09/16/1998	EP0863913A1 A method to increase the density of antigen on antigen presenting cells
09/16/1998	EP0863883A1 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
09/16/1998	EP0863766A1 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product
09/16/1998	EP0804462A4 An aglucone isoflavone enriched vegetable protein extract and isolate and process for producing
09/16/1998	EP0733205A4 Method for removal of binding proteins from ligands
09/16/1998	EP0724637B1 Corticotropin-releasing factor 2 receptors
09/16/1998	EP0706574B1 Methods for peptide synthesis and purification
09/16/1998	EP0691982B1 Separation of proteins
09/16/1998	EP0666920B1 Thrombin activatable plasminogen derivatives
09/16/1998	EP0649432B1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors
09/16/1998	EP0644897B1 New peptides and proteins, process for their preparation and their use as cholesterol acceptors
09/16/1998	EP0620854B1 Expression and purification of recombinant soluble tissue factor
09/16/1998	EP0530265B1 Dna encoding human 5-ht 1d receptors and uses thereof
09/16/1998	EP0493575B1 Rotavirus reassortant vaccine
09/16/1998	EP0478549B1 Products for inhibiting the adhesion, growth and/or survival of pathogens
09/16/1998	CN1193355A Alteration of amino acid compositions in seeds
09/16/1998	CN1193353A Allergen-XCD32 fusion proteins
09/16/1998	CN1193351A Method for identifying attenuated chickenpox virous OKA strain or strain originating therein
09/16/1998	CN1193350A Antigen non-specific glycosylation inhibiting factor derivatives
09/16/1998	CN1193349A Vaccine for infectious agents, compositions for treating and preventing HIV infections
09/16/1998	CN1193325A Cell adhension inhibitors
09/16/1998	CN1193324A Acellular pertussis vaccines and method of preparation thereof
09/16/1998	CN1193316A New cationic and polycationic amphiphiles, reagent containing same and their use
09/15/1998	US5808034 Genetic engineering
09/15/1998	US5808031 Human gene associated with arrest of cell growth and dna damage induction; diagnosis and treatment of cancer
09/15/1998	US5808030 Polypeptide
09/15/1998	US5808029 Genetic engineering
09/15/1998	US5808028 Molecular clone of a P58 receptor protein and uses thereof
09/15/1998	US5808026 Cancer detection, therapy
09/15/1998	US5808025 Polypeptide
09/15/1998	US5808024 Nucleic acids encoding high molecular weight major outer membrane protein of moraxella
09/15/1998	US5808012 Protein-enriched thermoplastics
09/15/1998	US5808011 Method for chromatographic removal of prions
09/15/1998	US5808009 Method of affinity purifying antibodies
09/15/1998	US5808008 Method of producing human pluripotent hematopoietic colony stimulating factor
09/15/1998	US5808007 Treating cell proliferative or immunologic disorders
09/15/1998	US5808006 Refolding of polypeptides like recombinant insulin-like growth factor IGF-I
09/15/1998	US5808005 Medical diagnosis; vaccines
09/15/1998	US5808004 Fragments of a lymphocyte adhesion receptor for high endothelium, CD44
09/15/1998	US5807998 Modified urf13-T protein
09/15/1998	US5807997 Method for immobilization of thiol compounds via activation of polymers, activated polymers, and products obtained by the method
09/15/1998	US5807996 Fused polypeptides comprising interleukin-4 polypeptide fragments
09/15/1998	US5807995 Diagnosis and treatment of cancer
09/15/1998	US5807993 HP-8 autoantigen
09/15/1998	US5807992 Vaccines; medical diagnosis
09/15/1998	US5807991 Human interleukin-5 receptor
09/15/1998	US5807989 Genetic and nervous system disorders; purified polypeptide
09/15/1998	US5807988 Isolation, characterization, and use of the human and subunit of the high affinity receptor for immunoglobulin E
09/15/1998	US5807986 Genetic engineering
09/15/1998	US5807982 Affinity purified heparin
09/15/1998	US5807981 Genetic engineering
09/15/1998	US5807980 Bovine pancreatic trypsin inhibitor derived inhibitors of factor VIIa-tissue factor complex
09/15/1998	US5807979 Genetic engineering; hybrids polypeptides
09/15/1998	US5807839 Method for stimulating red blood cell production
09/15/1998	US5807836 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity
09/15/1998	US5807831 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
09/15/1998	US5807828 Platelet aggregation inhibitors
09/15/1998	US5807827 Narcotic analgesic potentiation, narcotic withdrawal
09/15/1998	US5807826 Semaphorin gene family
09/15/1998	US5807825 Platelet aggregation inhibitors
09/15/1998	US5807824 C5A receptor antagonists having substantially no agonist activity
09/15/1998	US5807823 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
09/15/1998	US5807822 Insulin-like growth factor II as a pharmaceutical agent in the treatment of osteopenias
09/15/1998	US5807821 Treating cancer and post-surgery pain; side effect reduction, non-habit forming
09/15/1998	US5807819 Using an oligopeptide
09/15/1998	US5807818 Therapeutic uses of bactericidal/permeability increasing protein (BPI) protein products
09/15/1998	US5807746 Administering signal peptide complex; antisense therapy, gene transfer
09/15/1998	US5807745 Method of inhibiting PADGEM-mediated or ELAM-1-mediated leukocyte adhesion using an inhibitor comprising a Lex core component
09/15/1998	US5807742 Amplification copies of dna sequences
09/15/1998	US5807740 Regulators of UCP2 gene expression
09/15/1998	US5807738 Human fetoprotein
09/15/1998	US5807731 Antitumor
09/15/1998	US5807723 Homologously recombinant slow growing mycobacteria and uses therefor
09/15/1998	US5807714 Method of production of antigen-specific glycosylation inhibiting factor
09/15/1998	US5807713 Transforming growth factor
09/15/1998	US5807712 Genetic engineered protein
09/15/1998	US5807711 Parenchymal hepatocyte growth factors
09/15/1998	US5807710 Nucleic acids encoding stable mutants of D-N-α-carbamoylase
09/15/1998	US5807709 Secreted proteins and polynucleotides encoding them
09/15/1998	US5807708 Conservin nucleic acid molecules and compositions
09/15/1998	US5807706 Genetic engineering
09/15/1998	US5807705 Antigen recognized by patients with antibody associated paraneoplastic sensory neuronopathy, DNA encoding same and uses thereof
09/15/1998	US5807703 Secreted proteins and polynucleotides encoding them
09/15/1998	US5807702 Genetic engineering
09/15/1998	US5807698 Human cyclin E
09/15/1998	US5807693 Binding to immobilized protein; elution
09/15/1998	US5807692 P21WAF1 derivatives and diagnostic methods
09/15/1998	US5807691 Polypeptides having serotonin receptor activity (5HT5A), nucleic acids coding for these polypeptides and uses thereof
09/15/1998	US5807689 Bioanalysis
09/15/1998	US5807685 Lyme disease
09/15/1998	US5807681 Genetic engineering
09/15/1998	US5807678 Identification of gene mutations associated with congenital lipoid adrenal hyperplasia
09/15/1998	US5807672 Dna sequences, diagnosing tuberculosis
09/15/1998	US5807670 Oligonucleotide primers; genetic engineering
09/15/1998	US5807559 Compositions for generating T cell immunity against carbohydrate structures
09/15/1998	US5807557 Vaccine
09/15/1998	US5807556 Methods of preventing degeneration of myoplasties
09/15/1998	US5807552 Compositions for conferring immunogenicity to a substance and uses thereof
09/15/1998	US5807550 Antibodies specifically recognizing somatotropin binding proteins
09/15/1998	US5807549 Lymphocyte chemoattractant factor and uses thereof

1 ... 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 ... 2916